Respiratory reovirus 1/L induction of diffuse alveolar damage: Pulmonary fibrosis is not modulated by corticosteroids in acute respiratory distress syndrome in mice

Clinical Immunology

Volumn 103, Issue 3 I, 2002, Pages 284-295

  London, Lucille ^a   Majeski, Elizabeth I ^a   Altman Hamamdzic, Sanja ^a   Enockson, Candace ^a   Paintlia, Manjeet K ^a   Harley, Russell A ^a   London, Steven D ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Acute respiratory distress syndrome; Chemokines; Cytokines; Diffuse alveolar damage; Interferon ; MCP 1; Methylprednisolone

Indexed keywords

CHEMOKINE; CORTICOSTEROID; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; METHYLPREDNISOLONE; MONOCYTE CHEMOTACTIC PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL REGENERATION; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG SENSITIVITY; FEMALE; HEALING; HISTOPATHOLOGY; HYALINE MEMBRANE DISEASE; LUNG ALVEOLUS CELL; LUNG EXTRAVASCULAR FLUID; LUNG FIBROSIS; LUNG INFECTION; MACROPHAGE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; REOVIRUS; RESPIRATORY DISTRESS SYNDROME; VIRUS INFECTION;

EID: 0036089334     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2002.5214     Document Type: Article

References (56)

1. The acute respiratory distress syndrome
2. The role of the host defense response in the progression and outcome of ARDS: Pathophysiological correlations and response to glucocorticoid treatment
3. Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS
4. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome
5. Changes in the inflammatory response of the lung during acute respiratory distress syndrome: Prognostic indicators
6. High levels of IL- 8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome
7. Increased IL- 8 concentrations in the pulmonary edema fluid of patients with acute respiratory distress syndrome from sepsis
8. IL- 8 and the development of adult respiratory distress syndrome in at risk patient groups
9. Inflammatory cytokines in the BAL of patients with ARDS: Persistent elevation over time predicts poor outcome
10. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS: Plasma IL-1β and IL- 6 levels are consistent and efficient predictors of outcome over time
11. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock
12. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: A randomized controlled trial
13. Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS: Patterns of response and predictors of outcome
14. High-dose corticosteroids in patients with the adult respiratory distress syndrome
15. Respiratory reovirus 1/L induction of diffuse alveolar damage: A model of acute respiratory distress syndrome
16. Respiratory reovirus 1/L induction of intraluminal fibrosis: A model for the study of bronchiolitis obliterans organizing pneumonia
17. A simplified method for the analysis of hydroxyproline in biological tissues
18. Respiratory-mucosal lymphocyte populations induced by reovirus serotype 1 infection
19. Reovirus 1/L infection triggers cell type specific pro-inflammatory responses in resident mucosal cells which is dependent on the autocrine action of interferon-β
20. Effect of CD14 blockade in rabbits with Escherichia coli pneumonia and sepsis
21. Neutrophils are major contributors to intraparenchymal lung IL-1beta expression after hemorrhage and endotoxemia
22. Pulmonary cytokine and chemokine mRNA levels after inhalation of LPS in C57BL/6 mice
23. Induction of acute inflammatory lung injury by staphylococcal enterotoxin B
24. IL-1β-induced neutrophil recruitment and acute lung injury in hamsters
25. Hemorrhage and resuscitation induce alterations in cytokine expression and the development of acute lung injury
26. The intratracheal administration of endotoxin and cytokines. I. Characterization of LPS-induced IL-1 and TNF mRNA expression and the LPS-, IL-1-, and TNF-induced inflammatory infiltrate
27. Experimental reovirus 1/L infection of the lung: A model for the study of the lung in the context of mucosal immunity
28. G-CSF and IL-8 but not GM-CSF correlate with severity of pulmonary neutrophilia in acute respiratory distress syndrome
29. Effects of therapy with IL-1 receptor antagonist on pulmonary cytokine expression following hemorrhage and resuscitation
30. Contribution of TNF-α to pulmonary cytokine expression and lung injury after hemorrhage and resuscitation
31. Effects of therapy with soluble TNF receptor fusion protein on pulmonary cytokine expression and lung injury following haemorrhage and resuscitation
32. Morphologic changes in the lungs of anesthetized sheep following intravenous infusion of recombinant tumor necrosis factor alpha
33. Corticosteroid therapy in acute respiratory distress syndrome
34. Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome
35. Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment
36. Are corticosteroids salvage therapy for refractory acute respiratory distress syndrome?
37. Corticosteroid rescue in late paediatric acute respiratory distress syndrome
38. Role of early postnatal dexamethasone in respiratory distress syndrome
39. Corticosteroids inhibit endotoxin-induced lung lymph neutrophil stimulating activity in sheep
40. Modification of pulmonary responses to endotoxemia in awake sheep by steroidal and nonsteroidal anti-inflammatory agents
41. The intratracheal administration of endotoxin. X. Dexamethasone downregulates neutrophil emigration and cytokine expression in vivo
42. Glucocorticoid effects in an endotoxin-induced rat pulmonary inflammation model: Differential effects on neutrophil influx, integrin expression, and inflammatory mediators
43. Effect of cortisol-synthesis inhibition on endotoxin-induced porcine acute lung injury, shock, and nitric oxide production
44. A critical comparison of the hematologic, cardiovascular, and pulmonary response to steroids and nonsteroidal anti-inflammatory drugs in a model of sepsis and adult respiratory distress syndrome
45. Dexamethasone and indomethacin modify endotoxin-induced respiratory failure in pigs
46. Corticosteroids and the treatment of idiopathic pulmonary fibrosis: Past, present, and future
47. International consensus statement on idiopathic pulmonary fibrosis
48. Idiopathic pulmonary fibrosis: Diagnosis and treatment - International consensus statement
49. Results of single and bilateral lung transplantation in 131 consecutive recipients
50. Steroid-responsive bronchiolitis after human heart-lung transplantation
51. Pulmonary fibrosis: Pathways are slowly coming into light
52. Inhibitory effects of a lecithinized superoxide dismutase on bleomycin-induced pulmonary fibrosis in mice
53. Increased expression of transforming growth factor beta isoforms (beta 1, beta 2, beta 3) in bleomycin-induced pulmonary fibrosis
54. Regulation of alveolar macrophage transforming growth factor-beta secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat
55. Bleomycin-induced pulmonary fibrosis: Effects of steroid on lung collagen metabolism
56. Inhibition of collagen accumulation by glucocorticoids in rat lung after intratracheal bleomycin instillation